ArticleExpert systems with applications2025
Enhancing Text Datasets With Scaling and Targeting Data Augmentation to Improve BERT-Based Machine Learners.
Article in Expert systems with applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning for autism detection using clinical notes: A comparison of transfer learning for a transparent and black-box approach.Artificial intelligence in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Synthetic data is used to increase a dataset's size for machine learning when acquiring new data is difficult. However, this is difficult for text data due to its symbolic nature. Large language models have decreased this difficulty. Using autism spectrum disorder as a use case, we analyze how synthetic data chosen based on descriptive metrics impacts the performance of a downstream classifier. We leverage a finetuned multilabel, bidirectional encoder model to label textual descriptions of children's behaviors (N = 10892) with seven diagnostic criteria. We measure precision, recall, and F1 per label to compare the impact of augmentation schemes. We evaluate performance without augmentation (baseline), then compare data source (original versus synthetic), amount of data added (50% or 100% of baseline count), and method of augmentation (adding to one class via Data Targeting or to the entire dataset via Data Scaling). The data points were selected based on scores from our white-box metrics: type-token ratio, cosine similarity, and perplexity. We also conducted a qualitative evaluation of the data using expert feedback. This resulted in a consistent increase in recall (approximately 8 %) but a similarly consistent decrease in precision (approximately 10 %). Neither the white-box metrics nor the following standard-deviation-based stability analysis provided a clear relationship to our results in our model. Cost analysis showed that data targeting could lower the BioBERT model's cost. Overall, this study shows that different schemes should be favored depending on the intent of use, e.g., screening or diagnosing in medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.